Tony Zook is Director and Chief Executive Officer of NeoGenomics Inc (NEO). The company reported total compensation of $9,127,092 for fiscal year 2025.
| Salary | $601,539 |
|---|---|
| Bonus | $0 |
| Stock awards | $3,999,997 |
| Option awards | $3,998,235 |
| Non-equity incentive plan | $513,400 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $13,921 |
| Total | $9,127,092 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure NeoGenomics Inc filed April 6, 2026, accession 0001077183-26-000014.
| Peer-group chief executive median | $8,661,227 |
|---|---|
| Difference from that median | $465,865 |
| Percentile within the disclosed peer group | 60th |
| Peers with a disclosed figure | 15 |
Medians and percentiles are computed across the peer group NeoGenomics Inc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Tony Zook this page | Director and Chief Executive Officer | $9,127,092 |
| Warren Stone | President and Chief Operating Officer | $5,068,830 |
| Jeffrey Sherman | Chief Financial Officer | $4,681,428 |
| Christopher Smith | Former Director and Former Chief Executive Officer | $4,045,937 |
| Melody Harris | Former Chief Operations Officer and President, Oncology Data Solutions | $3,692,445 |
| Alicia Olivo | Executive Vice President, General Counsel & Business Development | $3,049,999 |
| Gary Passman | Chief Culture Officer | $2,443,195 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full NeoGenomics Inc compensation brief.
Tony Zook's compensation sits inside NeoGenomics Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.